Alabama
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Alaska
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Arizona
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Arkansas
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
California
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Colorado
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Connecticut
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Florida
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Georgia
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Illinois
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Indiana
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Iowa
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Kansas
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Kentucky
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Louisiana
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Massachusetts
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Michigan
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Missouri
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Nebraska
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
New Hampshire
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
New Jersey
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
New York
Great Neck; Biomedical Research Alliance of New York
Inhalation Solution for Patients with Cystic Fibrosis Lung Disease - Adults and minors
Great Neck; Biomedical Research Alliance of New York
The Irving Goldman Family Care Center of North Shore LIJ Health System is currently recruiting patients with mild cystic fibrosis lung disease to take part in a research study that tests the safety and efficacy of an experimental drug designed to treat their condition.
New Hyde Park; Biomedical Research Alliance of New York
Cystic Fibrosis Patients Taking Pulmozyme
New Hyde Park; Biomedical Research Alliance of New York
Cystic Fibrosis - Adults and minors
New Hyde Park; Biomedical Research Alliance of New York
Cystic Fibrosis - Adults
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
North Carolina
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Ohio
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Oklahoma
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Oregon
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Pennsylvania
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
South Carolina
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Texas
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Utah
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Vermont
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Virginia
Charlottesville; University of Virginia
Research Study for those with mild Cystic Fibrosis
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Washington
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
West Virginia
Morgantown; West Virginia University - Clinical Trials Research Unit
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Study Evaluating the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency (Altus 0000726)
Morgantown; West Virginia University - Clinical Trials Research Unit
Multi-Center, Multi-National, Randomized, Placebo-Controlled Trial of Azithromycin in Subjects with Cystic Fibrosis 6-18 years old, Culture Negative for Pseudomonas aeruginosa (AZ0004)
Morgantown; West Virginia University - Clinical Trials Research Unit
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects with Severe Lung Disease (TOPIC)
Morgantown; West Virginia University - Clinical Trials Research Unit
A Randomized, Open Label, Multicenter, Phase 3 Trial to Assess the Safety of Tobramycin Inhalation Powder (TIP) Compared to TOBI in Cystic Fibrosis (CF) Subjects (TIP 003)
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
Wisconsin
Various Cities; Research Center
Cystic Fibrosis Study CTBM100C2302
